CD5 positivity is reported to be associated with higher prevalence of bone marrow involvement, thrombocytopenia and worse survival outcomes,8 In contrast, we found CD5 + IVL to be associated with lower prevalence of thrombocytopenia, lower incidence of bone marrow involvement, and no significant difference in survival outcomes compared to CD5‐ IVL. The gene discussed is CD5; the disease is Thrombocytopenia.